Custopharm, Inc.
Industry
- Pharmaceuticals
- Drug Delivery
- Generic Drugs
Other Names/Subsidiaries
- Hikma Pharmaceuticals plc
Latest on Custopharm, Inc.
US Federal Trade Commissioner Christine Wilson’s plan to resign, which she announced in a 14 February Wall Street Journal commentary, will leave the agency with three Democratic commissioners and no v
Hikma has now completed its acquisition of US sterile injectables specialist Custopharm from Water Street Healthcare Partners, in a deal that promises to further expand its US injectables business.
Hikma is on the verge of closing a major deal that will see it bolster its already sizable US injectables business by acquiring Custopharm from Water Street Healthcare Partners in a deal worth up t
The US Federal Trade Commission has indicated that biopharma mergers would have a tougher time clearing the agency. But it’s decision not to intervene in Pfizer Inc. ’s $6.7bn acquisition of Arena P